#ACE2

alex rubinsteyn

iskander

Saw this paper by way of @apoorva_nyc: "Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants"https://www.biorxiv.org/content/10.1101/2020.07.21.214759v1.abstractMy instinct is to expect any preprint on this top

Peter Higgins

ibddoctor

THREAD: More data about PPIs and SARS-CoV-2 coming out. Is there a consistent association across studies? @statsepi @DrToddLee @supermarioelia @mikejohansenmd @ADAlthousePhD Increased prevalence of ARDS in those taking PPI at

Nicholas A. Christakis

NAChristakis

Let’s talk about the fact that both the attack rate and the death rate among the young is indeed very low with COVID19, unlike most prior pandemics. And let’s speculate

Stefan Marciniak

Prof_Marciniak

The new Variant Under Investigation (VUI) was re-designated Variant of Concern (VOC) 202012/01 on 18 DecemberThis is an excellent report by @PHE_UK, but it’s a bit technical so I’ll try

Andy Slavitt @ 🏡🇺🇸

ASlavitt

NEW: There is a new strain of COVID in England that is far more infectious. What it means and what it doesn’t mean. Doing a Sat morning roundup with a

BTS ARMY Medical Union⁷

armymedunion

Happy New Year from BAMU! We're starting the year off with part 2 of our #BAMUCOVIDSeries this time talking about how this nasty virus affects our bodies and cause symptoms.

Eric Feigl-Ding

DrEricDing

Mutation “feat never seen before”...UPDATE on UK strain of #SARSCoV2 & how it evolved so fast:Variant B.1.1.7 (aka VUI-202012-01) has 23 mutations—but acquired suddenly 17 mutations “all at once”—which

Rommie Amaro

RommieAmaro

In a new @biorxivpreprint with @McLellan_Lab @ltchong @Terrasztain @LCasalino88 @fiona_chembot @JoryGoldsmith, we show how a glycan gate (at position N343) controls the opening of the #SARSCoV2 spike protein #GlycanGate #glycotimehttps://ww

Emanuel Wyler

ewyler

Out now! Our preprint on longitudinal lung and blood single-cell RNA-seq, and proteomics, of SARS-CoV-2 infected Syrian hamsters! Fantastic collaboration of labs from @ChariteBerlin @FU_Berlin @MDC_Berlin @BIMSB_MDC https://www.biorxiv.org/

Rüdiger Groß

r_gross_

Clinical studies have found impaired glucose homeostasis & ketoacidosis in COVID-19 patients - begs the question: does COVID-19/SARS-CoV-2 cause diabetes? We get closer to finding an answer with our new

Ceron Lab

CeronLab

I've been reading a bit about the new #SARSCoV2 in #UK. I made a figure and this thread to better understand this #UKvariant with 9 mutations in the Spike Protein.

Dr Emma Hodcroft

firefoxx66

Recently reported #SARSCoV2 #COVID19 '#mink mutation' in #Denmark is getting a lot of attention right now, but officially we know almost nothing about the variants/mutations in question.From an SSI report

Dr. Angela Rasmussen

angie_rasmussen

Hard agree. And if this is useful, let me share something that often gets omitted (not by @kakape).Variants always emerge, & are not good or bad, but expected. The challenge

Matt Hall

cispt2

We've posted an updated version of @ScientistShrimp @sckales TMPRSS2 @biorxivpreprint with some new information about active enzyme concentration in the assay. We also show the camostat metabolite is almost as

Dr. Ali Nouri

AliNouriPhD

#SARSCoV2 from transmissionto disease:1. Spike protein on the virus binds the ACE2 receptor on human cells. The Virus RNA is released into the cell, where it is translated into proteins

Matt McCarthy

DrMattMcCarthy

Here are 3 #COVID19 questions we're trying to answer:1. Why do monoclonal antibodies fail hospitalized patients? Cocktails made by Eli Lilly & Regeneron may be useful for high-risk outpatients, but

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.